Dat Inhibitor
Dat Inhibitor - Related Videos
01:52
Eukaryotic Transcription Inhibitors
0 Views •
2020
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells. Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
04:00
Modelling Intratumoral Treatment with miRNA Inhibitors: A Method to Analyze the Effect of miRNA Inhibitors on Tumor Growth in Murine Model
0 Views •
2023
This video demonstrates the in vivo delivery of miRNA inhibitors as therapeutic agents against tumor growth in orthotopic mouse models. The intratumoral administration of synthetic miRNA inhibitors or antagomiRs allows them to bind and inhibit endogenous miRNAs, thereby causing mRNA upregulation and suppression of tumor growth.
02:08
Assessing Bacterial Swarming Using a Gradient Inhibitor Plate
0 Views •
2025
Source: Guo, S., et al. Quantifying Bacterial Surface Swarming Motility on Inducer Gradient Plates. J. Vis. Exp. (2022).This video demonstrates the use of a double-layer gradient swarm plate to study bacterial swarming behavior under varying inhibitor concentrations. A plate with a gradient-forming inhibitor in the bottom layer is inoculated with bacteria and incubated. Images are captured at regular intervals to analyze the effect of inhibitor concentration on bacterial swarming.
10:33
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
0 Views •
Cited by 4 •
2015
We describe implementation of the REPLACE strategy for targeting protein-protein interactions. REPLACE is an iterative strategy involving synthetic and computational approaches for the conversion of optimized peptidic inhibitors into drug like molecules.
02:57
Evaluating Inhibitor Effects on Pellicle Formation in Bacillus subtilis
0 Views •
2026
Source: Bucher, T., et al. Methodologies for Studying B. subtilis Biofilms as a Model for Characterizing Small Molecule Biofilm Inhibitors. J. Vis. Exp. (2016)This video demonstrates a pellicle formation assay using Bacillus subtilis to evaluate small-molecule inhibitors that disrupt matrix synthesis and biofilm development, providing a model to screen compounds that selectively inhibit surface-associated growth without affecting free-floating cells.
FAQs
DAT inhibition changes dopamine signaling primarily by slowing clearance after release. Because dopamine remains in the synaptic space longer, signaling can persist and reach a higher concentration than it would with normal transporter activity. This makes DAT inhibitors useful for examining how the timing and strength of dopamine transmission shape neural responses.
The molecular interaction matters because it targets the dopamine-clearance step itself. By binding to or interfering with DAT, the compound changes transporter-mediated handling of dopamine without being described as a general alteration of neural signaling. This provides a focused way to connect transporter activity with changes in dopamine concentration and signaling duration.
Researchers can interpret changes produced by a DAT inhibitor in relation to the transporter's established role in dopamine clearance. If a neural or behavioral change accompanies prolonged or stronger dopamine signaling, the result supports a transporter-mediated contribution. This approach helps separate effects linked to DAT from effects involving other neural targets.
These compounds are especially informative when a study examines reward, motivation, movement, or attention. In each case, the inhibitor changes the persistence and concentration of dopamine signaling, allowing investigators to ask how altered transporter-mediated clearance relates to the function under study. The same framework supports comparisons across several neural and behavioral domains.
They provide a pharmacological way to focus on the consequences of reduced dopamine clearance when investigating psychostimulant-related neural mechanisms. Because the manipulation acts at DAT, researchers can examine whether changes in signaling duration and concentration help explain observed responses. This makes transporter activity a specific experimental entry point within broader studies of psychostimulant action.
Their value lies in connecting transporter-mediated dopamine changes with functions often examined in disorder research, including movement, attention, reward, and motivation. DAT inhibitors support investigations of how altered dopamine signaling relates to these processes. They therefore help researchers study transporter-related mechanisms without treating every observed neural or behavioral effect as specific to DAT.